A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

NCT00518271 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

NCT02963103 ·Status: TERMINATED ·Phase: PHASE4

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

NCT00519116 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic Studies of Tacrolimus in Transplant Patients

NCT01889758 ·Status: COMPLETED ·Phase: PHASE4

Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients

NCT02014103 ·Status: COMPLETED ·Phase: PHASE4

Optima: Optimizing Prograf Therapy in Maintenance Allografts II

NCT00905515 ·Status: COMPLETED ·Phase: PHASE4

A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection

NCT00717470 ·Status: COMPLETED ·Phase: PHASE4

TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic

NCT00552201 ·Status: COMPLETED ·Phase: PHASE4

A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

NCT02147938 ·Status: COMPLETED

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

NCT00282568 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

NCT01332201 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

NCT00717678 ·Status: COMPLETED ·Phase: PHASE3

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

NCT00384137 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

NCT01294020 ·Status: COMPLETED ·Phase: PHASE2

Tacrolimus to Sirolimus Conversion for Delayed Graft Function

NCT00931255 ·Status: TERMINATED ·Phase: PHASE4

A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant

NCT00005113 ·Status: TERMINATED ·Phase: PHASE3

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

NCT00275535 ·Status: COMPLETED ·Phase: PHASE4

Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx

NCT01187953 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

NCT00248313 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients

NCT02706678 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

NCT00895583 ·Status: COMPLETED ·Phase: PHASE4

Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

NCT00481481 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

NCT00273871 ·Status: COMPLETED ·Phase: PHASE3

Optimizing Prograf® Therapy in Renal Transplant Patients

NCT00297765 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

NCT00817206 ·Status: COMPLETED ·Phase: PHASE3